25 episodes

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
Hosted on Acast. See acast.com/privacy for more information.

eMultipleSclerosis Review eMultipleSclerosis Review

    • Health & Fitness
    • 5.0 • 2 Ratings

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
Hosted on Acast. See acast.com/privacy for more information.

    Emerging MS Clinical Options

    Emerging MS Clinical Options

    Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what efficacy and safety?
    Join us, as guest host Dr. Cole Harrington from the Ohio State University explores these important topics in this issue of eMultipleSclerosis Review.
    Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/178/test)
    Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/176)

    Hosted on Acast. See acast.com/privacy for more information.

    • 24 min
    Clinical and Radiologic Features of an MS Prodrome

    Clinical and Radiologic Features of an MS Prodrome

    What’s the evidence supporting the existence of an MS prodromal phase — where the biology of the disease has begun but the symptoms typical of MS have not yet appeared? Are there biomarkers to help identify it? Imaging abnormalities? And how can diagnosing a prodrome benefit patients?
    Join us as we discuss these questions with Dr. Naila Makhani from Yale School of Medicine, in this video podcast issue of eMultipleSclerosis Review.
    Take our post-test to claim CME credits.
    Read this podcast's companion newsletter here.

    Hosted on Acast. See acast.com/privacy for more information.

    • 27 min
    Mitigating MS DMT Infection Risk

    Mitigating MS DMT Infection Risk

    Clinicians prescribing the increasingly higher efficacy B-cell depletion or S1P modulators therapies — how aware are they of the newer concerns about safety? Which of their patients may be in greater danger of acquiring PML and/or opportunistic infections? The vaccinations commonly recommended for the general population (eg, COVID-19) — do individuals with MS respond differently, and what should clinicians do about it? What do the data say?
    Join us, as Dr. Le Hua and Dr. Areeba Siddiqui from the Cleveland Clinic’s Lou Ruvo Center for Brain Health explore these questions in this issue of eMultipleSclerosis Review.
    Take our post-test to claim CME credits.
    Read this podcast's companion newsletter here.

    Hosted on Acast. See acast.com/privacy for more information.

    • 21 min
    Overcoming Barriers to MS Care

    Overcoming Barriers to MS Care

    Too many individuals with MS are not receiving access to the most effective care. Why? What’s behind these disparities? And what can individual clinicians do to help remove the barriers that prevent equitable care for all patients?Join us, as Dr. Dorlan Kimbrough, from the division of Neurology, Multiple Sclerosis, and Neuroimmunology at the Duke University School of Medicine, discusses these topics, in this issue of eMultipleSclerosis Review. 
    Take our post-test to claim CME credits.
    Read this podcast's companion newsletter here.

    Hosted on Acast. See acast.com/privacy for more information.

    • 23 min
    Clinical Opinions: Managing Spasticity in Individuals with MS

    Clinical Opinions: Managing Spasticity in Individuals with MS

    How burdensome is spasticity for patients with MS? What’s the approach to treatment, and how effective is it? What do patients and clinicians need to know about cannabis-based therapies?  
    These are the key questions Program Director Dr. Michael Kornberg from the Johns Hopkins School of Medicine discusses with guest MS spasticity experts in this second part of this eMultipleSclerosis Review Special Edition. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    Hosted on Acast. See acast.com/privacy for more information.

    • 41 min
    MS Risk Factors and Outcomes

    MS Risk Factors and Outcomes

    In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer data describing the modifiable and nonmodifiable risk factors for developing MS and/or increasing the rate of disease progression and disability.
    Join us for this podcast as Dr. Ward explains how these findings can affect clinical practice to improve overall care of individuals with MS. 
    Take our post-test to claim CME credits.
    Read this podcast's companion newsletter here.

    Hosted on Acast. See acast.com/privacy for more information.

    • 17 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
ZOE Science & Nutrition
ZOE
The School of Greatness
Lewis Howes
On Purpose with Jay Shetty
iHeartPodcasts
Nothing much happens: bedtime stories to help you sleep
iHeartPodcasts
Passion Struck with John R. Miles
John R. Miles